These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20040642)

  • 1. Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds.
    Ravindran V; Hughes RA
    J Rheumatol; 2010 Jan; 37(1):200; author reply 201-2. PubMed ID: 20040642
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context?
    Dessein PH; Christian BF; Solomon A
    J Rheumatol; 2009 Jul; 36(7):1357-61. PubMed ID: 19567631
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor?
    Quyyumi AA
    Circulation; 2006 Sep; 114(11):1137-9. PubMed ID: 16966595
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and cardiovascular risk factors in rheumatoid arthritis.
    Armstrong DJ; McCausland EM; Quinn AD; Wright GD
    Rheumatology (Oxford); 2006 Jun; 45(6):782; author reply 782-3. PubMed ID: 16632480
    [No Abstract]   [Full Text] [Related]  

  • 8. New insight into rheumatoid arthritis management. The disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture.
    Duke Med Health News; 2012 Feb; 18(2):1-2. PubMed ID: 22397007
    [No Abstract]   [Full Text] [Related]  

  • 9. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study.
    Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK
    Ann Rheum Dis; 2011 May; 70(5):812-7. PubMed ID: 21288959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis].
    Lindhardsen J; Gislason GH; Ahlehoff O; Madsen OR; Hansen PR
    Ugeskr Laeger; 2011 Jan; 173(5):343-6. PubMed ID: 21276397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease.
    Friedewald VE; Ganz P; Kremer JM; Mease PJ; O'Dell JR; Pearson TA; Ram CV; Ridker PM; Salmon JE; Roberts WC
    Am J Cardiol; 2010 Aug; 106(3):442-7. PubMed ID: 20643261
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.
    Nasir A; Greenberg JD
    Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].
    Pind R
    Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
    Cleland LG; Caughey GE; James MJ; Proudman SM
    J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases.
    Turesson C; Matteson EL
    Curr Opin Rheumatol; 2007 Mar; 19(2):190-6. PubMed ID: 17278937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.
    Giles JT; Post W; Blumenthal RS; Bathon JM
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheumatoid arthritis (updated Current Care guideline)].
    Hakala M; Hannonen P; Helve T; Korpela M; Mattila K; Möttönen T; Varis T;
    Duodecim; 2009; 125(19):2131-2. PubMed ID: 19938416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.